APstem Therapeutics
PrivateLast Round
VC Round
Sep 7, 2023
Total Funding Raised
$4.3M
Momentum Score
25 /100
Company Overview
APstem Therapeutics is a private biopharmaceutical company that develops regenerative cell therapies based on its patented, proprietary stem cell platform called Guide-Integrated Adult Stem Cells (giaSCs), also known as APSCs. The company's mission is to address chronic and incurable diseases by restoring the body's natural regenerative capabilities. Their initial focus is on treating Type 1 Diabetes Mellitus (T1D) and chronic wounds like diabetic ulcers. The company's technology is based on a discovery licensed from Stanford University and aims to provide a therapy that is safe, scalable, and does not carry the risks associated with other stem cell types. APstem's platform has a dual mechanism of action, stimulating tissue regeneration while also suppressing autoimmune inflammation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
APstem Therapeutics Comps
Public and private peers based on sector, stage, and business model.
APstem Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 7, 2023 | ||||
| Seed | Sep 1, 2020 | ||||
| Seed | May 1, 2019 | ||||
| Seed | Jan 17, 2018 | ||||
| Accelerator | Jan 1, 2017 |
APstem Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Seed, Accelerator |
| Beyond Ventures | Seed |
| MFund | Seed |
| Oriza Ventures | Seed |
| InnoSpring | Seed |
APstem Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about APstem Therapeutics's valuation, stock price, and market status.
